Bicycle Therapeutics plc

US$3.61As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BCYCHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (14.61%)
Div yield —
ROE (25.24%)
Biotechnology
Beta (5Y) 1.61
PE TTM —
TSR TTM (55.27%)
Mkt cap US$253.0M
ROIC (16.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.93
8.74%
(61.33%)
Hold 12|1|8|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
20.04%
2.20%
18.59%
6.97%
Revenue$M
22.54
23.57
23.85
24.57
5.65%
11.93%
8.77%
7.95%
Peers (US$253.0M)
Cap (US$)
PE
393.9M
203.0x
352.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.329
0.312
0.321
EBIT/Intx
0.508
0.252
0.269
Own earn%
23.39
28.34
37.12
Sh yield%
31.96
35.67
34.35
Owners
Insiders/Inst%
4.91
70.21
Short interest%
5.76
SBC / revenue%
4.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
14–22
$1 testx
—
Incr. ROIC%
17